12:00 AM
 | 
Sep 10, 2012
 |  BC Week In Review  |  Company News  |  Other News

Sarepta Therapeutics, U.S. Department of Defense infectious news

Sarepta received a $3.9 million contract from DoD's Joint Project Manager Transformational Medical Technologies (JPM-TMT) program to evaluate the feasibility of intramuscular formulation of AVI-7288...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >